Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Histologic Type × Interleukin-2 × 1 year × Clear all

Sponsor

Conditions

Melanoma 19 Neoplasm Metastasis 8 Lymphoma, Non-Hodgkin 8 Skin Neoplasms 6 Ovarian Neoplasms 6 Leukemia, Myeloid, Acute 6 Colorectal Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Leukemia, Lymphocytic, Chronic, B-Cell 5 Uveal Melanoma 4 Squamous Cell Carcinoma of Head and Neck 4 Neoplasms 4 Lymphoma 4 Triple Negative Breast Neoplasms 3 Stomach Neoplasms 3 Recurrence 3 Multiple Myeloma 3 Mesothelioma, Malignant 3 Lymphoma, Follicular 3 Lung Neoplasms 3 Leukemia 3 Esophageal Neoplasms 3 Carcinoma, Renal Cell 3 Uterine Cervical Neoplasms 2 Sarcoma 2 Rectal Neoplasms 2 Pleural Effusion, Malignant 2 Pancreatic Neoplasms 2 Neuroblastoma 2 Myelodysplastic Syndromes 2

Interventions

fludarabine 4 Cisplatin 4 atezolizumab 3 Pemetrexed 3 Cyclophosphamide 3 pralsetinib 2 pembrolizumab 2 fludarabine phosphate 2 entrectinib 2 durvalumab 2 cobimetinib 2 capmatinib 2 alectinib 2 Whole-Body Irradiation 2 Vemurafenib 2 Tacrolimus 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Paclitaxel 2 Nivolumab 2 Mycophenolic Acid 2 Mesna 2 Melphalan 2 Busulfan 2 130-nm albumin-bound paclitaxel 2 trametinib 1 spartalizumab 1 ruxolitinib 1 repotrectinib 1 ponatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡